About US
Contact us
-
SNL veteran Vanessa Bayer joins Allergan for birth control Q&A on streets of NYCIt wasn’t all that long ago that Allergan unveiled a purple-haired, fashion-forward cartoon as the face of its birth control awareness efforts. With its latest campaign, though, it’s going a little mo2017/8/28
-
Shire tweaks popular hemophilia app platform to serve hard-to-treat patientsShire last week moved to help hemophiliacs with inhibitors better manage their disease digitally. The pharmastrucka deal with independent hemophilia platform MicroHealth tocustomize its existing app t2017/8/28
-
HPV vaccination rates ticking upward, CDC says as it urges more uptakeEfforts to boost the national HPV vaccination rate are yielding some positive results, new data from the CDC show. Nationwide, 60% of teens ages 13 to 17 received at least one dose of the shot last ye2017/8/27
-
FDA targets rogue clinic using Sanofi's smallpox vaccine in unapproved cancer therapyAs part of a recent crackdown on stem cell clinics, the FDA found an operation using Sanofi's smallpox vaccine in an illegitimate cancer therapy. U.S. Marshals seized five vials of the vaccine, a con2017/8/27
-
AstraZeneca oldie Faslodex nets another breast cancer approvalAstraZeneca may have recently hit a snag in the immuno-oncology space, but it got a boost Monday elsewhere in its cancer portfolio. The FDAexpandeduse of Faslodex, granting AZ an indication for solo2017/8/25
-
Allergan heads to federal court to defend Restasis against early generic rivalsIn defense of a top seller, Allergan is squaring off against generics companies in Texas federal court, accusing copycat makersof violating its patent protections on blockbuster eye medication Restasi2017/8/25
-
Allergan hits its already battered Irvine site with another round of job cutsMore than 100 layoffs are on the way at Allergan. The company earlier this month filed a WARNnoticewith state of California,saying it would dismiss 109 employees at its ex-headquarters in Irvine. The2017/8/24
-
Valeant denies bypassing eye-device maker Iconlabs in M&A bid for lens techAfter a disastrous two years for Valeant, the company faces a lawsuit alleging it “engaged in willful ignorance” to bypass a would-be partner and acquire intraocular lens technology from a third-party2017/8/24
-
Alexion wins 3 new Soliris patents as Amgen works on biosimilar of pricey drugWith a Soliris biosimilar showing up in its rearview mirror, Alexion is piling on patents for its superexpensive drug, hoping to put some more distance between it and any sales-grabbing copies. The2017/8/23
-
Johnson & Johnson expected to keep battling talc claims despite losses: expertHaving lost four talc cases worth more than $300 million, Johnson & Johnson is engaged in a tough legal battle against thousands of liability claims alleging routine use caused ovarian cancer. Des2017/8/23